AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OKYO Pharma Ltd Director's Dealing 2022

May 16, 2022

34361_dirs_2022-05-16_b6d8303c-514a-4671-9a22-c8edff85ab07.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OKYO Pharma Ltd (OKYO)
CIK: 0001849296
Period of Report: 2022-05-16

Reporting Person: CERRONE GABRIELE M (Director, Executive Chairman, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	543181215	Indirect

Footnotes

F1: 511,166,362 ordinary shares owned by Panetta Partners Ltd and 32,014,853 ordinary shares owned by Planwise Group Ltd. Mr. Cerrone is the ultimate beneficial owner of the ordinary shares held by Planwise Group Ltd and Panetta Partners Ltd.